BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9177396)

  • 1. Somatostatin receptor subtype expression in human thyroid and thyroid carcinoma cell lines.
    Ain KB; Taylor KD; Tofiq S; Venkataraman G
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1857-62. PubMed ID: 9177396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin receptor subtype gene expression in pituitary adenomas.
    Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives.
    Zatelli MC; Piccin D; Tagliati F; Bottoni A; Luchin A; Vignali C; Margutti A; Bondanelli M; Pansini GC; Pelizzo MR; Culler MD; Degli Uberti EC
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2218-24. PubMed ID: 16569735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of somatostatin receptors (SSTRs) expression and antiproliferative effect of somatostatin analogues in aggressive thyroid cancers.
    Carmona Matos DM; Jang S; Hijaz B; Chang AW; Lloyd RV; Chen H; Jaskula-Sztul R
    Surgery; 2019 Jan; 165(1):64-68. PubMed ID: 30415874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
    Forssell-Aronsson EB; Nilsson O; Bejegård SA; Kölby L; Bernhardt P; Mölne J; Hashemi SH; Wängberg B; Tisell LE; Ahlman H
    J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin analogs affect proliferation of human thyroid carcinoma cell lines in vitro.
    Ain KB; Taylor KD
    J Clin Endocrinol Metab; 1994 May; 78(5):1097-102. PubMed ID: 7909817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor subtype expression in human thyroid tumours.
    Klagge A; Krause K; Schierle K; Steinert F; Dralle H; Fuhrer D
    Horm Metab Res; 2010 Apr; 42(4):237-40. PubMed ID: 20094970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortistatin-14 inhibits cell proliferation of human thyroid carcinoma cell lines of both follicular and parafollicular origin.
    Cassoni P; Muccioli G; Marrocco T; Volante M; Allia E; Ghigo E; Deghenghi R; Papotti M
    J Endocrinol Invest; 2002 Apr; 25(4):362-8. PubMed ID: 12030609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin receptors in primary human breast cancer: quantitative analysis of mRNA for subtypes 1--5 and correlation with receptor protein expression and tumor pathology.
    Kumar U; Grigorakis SI; Watt HL; Sasi R; Snell L; Watson P; Chaudhari S
    Breast Cancer Res Treat; 2005 Jul; 92(2):175-86. PubMed ID: 15986128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors.
    Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y
    J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization.
    Reubi JC; Schaer JC; Waser B; Mengod G
    Cancer Res; 1994 Jul; 54(13):3455-9. PubMed ID: 8012966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
    Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different expression patterns of somatostatin receptor subtypes in cultured epithelial cells from human normal prostate and prostate cancer.
    Sinisi AA; Bellastella A; Prezioso D; Nicchio MR; Lotti T; Salvatore M; Pasquali D
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2566-9. PubMed ID: 9253335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subtype-selective expression of the five somatostatin receptors (hSSTR1-5) in human pancreatic islet cells: a quantitative double-label immunohistochemical analysis.
    Kumar U; Sasi R; Suresh S; Patel A; Thangaraju M; Metrakos P; Patel SC; Patel YC
    Diabetes; 1999 Jan; 48(1):77-85. PubMed ID: 9892225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-clinical and clinical experiences with novel somatostatin ligands: advantages, disadvantages and new prospects.
    Hofland LJ; van der Hoek J; Feelders R; van der Lely AJ; de Herder W; Lamberts SW
    J Endocrinol Invest; 2005; 28(11 Suppl International):36-42. PubMed ID: 16625843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Laminin receptors in differentiated thyroid tumors: restricted expression of the 67-kilodalton laminin receptor in follicular carcinoma cells.
    Montuori N; Müller F; De Riu S; Fenzi G; Sobel ME; Rossi G; Vitale M
    J Clin Endocrinol Metab; 1999 Jun; 84(6):2086-92. PubMed ID: 10372715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells.
    Bruno JF; Xu Y; Berelowitz M
    Biochem Biophys Res Commun; 1994 Aug; 202(3):1738-43. PubMed ID: 7914724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative and functional expression of somatostatin receptor subtypes in human prolactinomas.
    Jaquet P; Ouafik L; Saveanu A; Gunz G; Fina F; Dufour H; Culler MD; Moreau JP; Enjalbert A
    J Clin Endocrinol Metab; 1999 Sep; 84(9):3268-76. PubMed ID: 10487698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of tamoxifen and somatostatin analogue on growth of human medullary, follicular, and papillary thyroid carcinoma cell lines: tissue culture and nude mouse xenograft studies.
    Weber CJ; Marvin M; Krekun S; Koschitzky T; Karp F; Benson M; Feind CR
    Surgery; 1990 Dec; 108(6):1065-71. PubMed ID: 1978945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution of somatostatin receptor subtype messenger ribonucleic acid in the rat.
    Bruno JF; Xu Y; Song J; Berelowitz M
    Endocrinology; 1993 Dec; 133(6):2561-7. PubMed ID: 8243278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.